Dynavax Technologies | Profitto Lordo Sulle Vendite



Gross Profit On Sales Cambiamento Data
AbbVie USD 9.34B 1.36B 2025-03
Adma Biologics USD 63.33M 3.67M 2024-12
Amgen USD 5.54B 430M 2025-03
AstraZeneca USD 11.98B 637M 2025-06
Biogen USD 2.04B 238.8M 2025-06
BioMarin Pharmaceutical USD 593.59M 17.59M 2025-03
Bristol-Myers Squibb USD 8.9B 714M 2025-06
Dynavax Technologies USD 54.4M 4.23M 2025-03
Gilead Sciences USD 5.99B 17M 2024-12
Glaxosmithkline GBP 5.6B 94M 2024-12
Merck USD 12.99B 224M 2025-06
Neurocrine Biosciences USD 676.2M 112.8M 2025-06
Novartis USD 11.51B 1.12B 2025-06
Pfizer USD 11.12B 987M 2025-03
Regeneron Pharmaceuticals USD 2.56B 659.4M 2025-03
Roche Holding CHF 11.69B 48M 2024-12
Sarepta Therapeutics USD 607.29M 81.18M 2025-03
TG Therapeutics USD 92.79M 18.25M 2024-12
Vertex Pharmaceuticals USD 2.49B 109.3M 2024-12


Dynavax Technologies Profitto Lordo Sulle Vendite - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Aug 2025.